The right expertise and actions, no matter what the drug phase

A successful drug or biological is one that has all the components of reimbursement working – coverage, coding, payment and access. DKP is well-known for its thoughtful strategic approach to reimbursement for oncology and rare diseases that doesn’t only provide a 10,000 foot view, but also an understanding of how care is delivered at the patient level. This means identifying the implications to providers, payers, and patients.

No matter whether you are assessing a licensing opportunity, preparing for and launching a new asset, or managing a more mature product, DKP can effectively support corporate objectives. Whether through the DKP Lifecycle Solutions™ strategic consulting services, or DKP PayerScope® market monitoring services, DKP connects you with the important information required to understand and act – no matter what phase of life your product is in.

Questions?

We'd love to help you. Give us a call at (317) 873-0303.

Send us a message
  • This field is for validation purposes and should be left unchanged.